Evora PRB - Search Results

1

Indigo Carmine Hemodynamic Studies to Treat Vasoplegia Induced by Compound 48/80 in a Swine Model of Anaphylaxis.

Albuquerque AAS, Celotto AC, Becari C, Prandi M, Barbosa JM, Moreira F Neto, Jordani MC, Evora PRB. Albuquerque AAS, et al. Among authors: evora prb. Braz J Cardiovasc Surg. 2022 Mar 10;37(1):20-28. doi: 10.21470/1678-9741-2020-0622. Braz J Cardiovasc Surg. 2022. PMID: 35274519 Free PMC article.

2

In vitro pharmacological study of femoral artery vascular reactivity after inferior canine hindlimb ischemia/reperfusion: effects of in vivo nitric oxide blocker infusion.

Joviliano EE, Piccinato CE, Cherri J, Viaro F, Moryia T, Celotto AC, Bonaventura D, Evora PR. Joviliano EE, et al. Ann Vasc Surg. 2007 Sep;21(5):618-28. doi: 10.1016/j.avsg.2007.07.004. Ann Vasc Surg. 2007. PMID: 17823044

3

Compound 48/80 induces endothelium-dependent and histamine release-independent relaxation in rabbit aorta.

Viaro F, Celotto AC, Capellini VK, Baldo CF, Rodrigues AJ, Vicente WV, Evora PR. Viaro F, et al. Nitric Oxide. 2008 Mar;18(2):87-92. doi: 10.1016/j.niox.2007.11.004. Epub 2007 Nov 28. Nitric Oxide. 2008. PMID: 18078832

4

Endothelium dysfunction classification: why is it still an open discussion?

Evora PR, Baldo CF, Celotto AC, Capellini VK. Evora PR, et al. Int J Cardiol. 2009 Oct 2;137(2):175-6. doi: 10.1016/j.ijcard.2008.05.031. Epub 2008 Aug 3. Int J Cardiol. 2009. PMID: 18676040

5

Pharmacology of the human saphenous vein.

Joviliano EE, Dellalibera-Joviliano R, Celotto AC, Capellini VK, Dalio MB, Picconato CE, Evora PR. Joviliano EE, et al. Curr Vasc Pharmacol. 2011 Jul 1;9(4):501-20. doi: 10.2174/157016111796197260. Curr Vasc Pharmacol. 2011. PMID: 21143161 Review.

6

Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma.

Evora PR, Evora PM, Capellini VK, Celotto AC. Evora PR, et al. Int J Cardiol. 2011 Sep 15;151(3):365-6. doi: 10.1016/j.ijcard.2011.06.089. Epub 2011 Jul 2. Int J Cardiol. 2011. PMID: 21724277 Free article. No abstract available.

7

Human saphenous vein "no-touch" harvesting and vasa vasorum.

Evora PR, Celotto AC. Evora PR, et al. J Thorac Cardiovasc Surg. 2011 Aug;142(2):474-5. doi: 10.1016/j.jtcvs.2011.01.066. J Thorac Cardiovasc Surg. 2011. PMID: 21763879 Free article. No abstract available.

8

Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Farina Junior JA, Celotto AC, da Silva MF, Evora PR. Farina Junior JA, et al. Med Sci Monit. 2012 May;18(5):HY13-7. doi: 10.12659/msm.882718. Med Sci Monit. 2012. PMID: 22534716 Free PMC article. Review.

9

Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview.

Evora PR, Evora PM, Celotto AC, Rodrigues AJ, Joviliano EE. Evora PR, et al. Curr Drug Targets. 2012 Aug;13(9):1207-14. doi: 10.2174/138945012802002348. Curr Drug Targets. 2012. PMID: 22716077 Review.

10

Curbing inflammation in the ischemic heart disease.

Evora PR, Nather J, Tubino PV, Albuquerque AA, Celotto AC, Rodrigues AJ. Evora PR, et al. Int J Inflam. 2013;2013:183061. doi: 10.1155/2013/183061. Epub 2013 May 30. Int J Inflam. 2013. PMID: 23819098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters